Hans J. W. R. Nortier

Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly

Ab A. Aaldriks, Ed Maartense, Hans J. W. R. Nortier et al. · Acta Oncologica · 2015 · 60 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Physical activity and survival of postmenopausal, hormone receptor–positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

Nienke A. de Glas, D.B.Y. Fontein, Esther Bastiaannet et al. · Cancer · 2014 · 55 citations

Medicine, Oncology, Breast Oncology +14

Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia

Maureen J.B. Aarts, Frank Peters, Caroline M.P.W. Mandigers et al. · Journal of Clinical Oncology · 2013 · 49 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Cost Effectiveness of Primary Pegfilgrastim Prophylaxis in Patients With Breast Cancer at Risk of Febrile Neutropenia

Maureen J.B. Aarts, Janneke P.C. Grutters, Frank Peters et al. · Journal of Clinical Oncology · 2013 · 42 citations

Pharmacy, Oncology, Pharmacoeconomics +13